References
- Eriksson S. Studies in alpha1-antitrypsin deficiency. Acta Med Scand 1965; 177(Suppl. 432)1–85
- Sobonya R E, Burrows B. The epidemiology of emphysema. Clin Chest Med 1983; 4: 351–8
- Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985; 132: 417–33
- Gadek J E, Fells G A, Crystal R G. Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. Science 1979; 206: 1315–6
- Carp H, Miller F, Hoidal J R, Janoff A. Potential mechanisms of emphysema: Alpha1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci USA 1982; 79: 2041–45
- Stone P J, Calore J D, McGowan S E, Bernardo J, Snider G L, Franzblau C. Functional alpha1-protease inhibitor in the lower respiratory tract of cigarette smokers is not decreased. Science 1983; 221: 1187–9
- Boudier C, Pelletier A, Pauli G, Bieth J G. The functional activity of alpha1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers. Clin Chim Acta 1983; 132: 309–15
- Stockley R A, Afford S C. Qualitative studies of lung lavage alpha1-proteinase inhibitor. Hoppe Seylers Z Physiol Chem 1984; 365: 503–10
- Abboud R T, Fera T, Richter A, Tabona M Z, Johal S. Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid. Am Rev Respir Dis 1985; 131: 79–85
- Chowdhury P, Bone R C, Louria D B, Rayford R L. Effect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentrations. Am Rev Respir Dis 1982; 126: 177–9
- Lellouch J, Claude J-R, Martin J-P, Orssaud G, Zaoui D, Bieth J G. Smoking does not reduce the functional activity of serum alpha1-proteinase inhibitor. An epidemiologic study of 719 healthy men. Am Rev Respir Dis 1985; 132: 818–20
- Gadek J E, Fells G A, Zimmerman R L, Rennard S I, Crystal R G. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest 1981; 68: 889–98
- Stockley R A, Morrison H M, Smith S, Tetley T. Low molecular mass bronchial proteinase inhibitor and alpha1-proteinase inhibitor in sputum and bronchoalveolar lavage. Hoppe Seylers Z Physiol Chem 1984; 365: 587–95
- Boudier C, Pelletier A, Gast A, Tournier J-M, Pauli G, Bieth J G. The presence of bronchial inhibitor and a hitherto unknown leukoproteinase inhibitor in human bronchoalveolar lavage fluids. Am Rev Respir Dis 1985; 131: A59, Abstract
- Boudier C. Aspects biochimiques de l'emphysème pulmonaire. Thèse 3ème cycle Biochimie. Strasbourg 1981
- Jeppson J-O, Laurell C B. Functional and chemical composition of alpha1-antitrypsin. Proteases and Biological Control, E Reich, B D Rifkin, E Shaw. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1975; 405–14
- Klasen E C, Kramps J A. The N-terminal sequence of antileukoprotease isolated from bronchial secretion. Biochem Biophys Res Com 1985; 128: 285–9
- Ohlsson K, Olsson I. Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest 1974; 34: 349–55
- Ohlsson K, Tegner H. Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest 1976; 36: 437–45
- Virca G D, Travis J. Kinetics of association of human proteinases with human alpha2-macroglobulin. J Biol Chem 1984; 259: 8870–4
- Nakajima K, Powers J C. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha1-protease inhibitor reactive site. J Biol Chem 1972; 254: 4027–32
- Kramps J A, van Twisk Ch, van der Linden A C. L-pyroglutamyl-L-prolyl-L-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase. Scand J Clin Lab Invest 1983; 43: 427–32
- Bieth J, Spiess B, Wermuth C G. The synthesis and analytical use of a highly sensitive and convenient substrate for elastase. Biochem Med 1974; 11: 350–7
- Beatty K, Matheson N, Travis J. Kinetic and chemical evidence for the inability of oxidized alpha1-proteinase inhibitor to protect lung elastin from elastolytic degradation. Hoppe Seylers Z Physiol Chem 1984; 365: 731–6
- Stockley R A, Morrison H M, Kramps J A, Dijkman J H, Burnett D. Studies of proteinase and their inhibitors in lung secretions. Eur J Resp Dis, (in press)
- Bruch M, Bieth J G. Influence of elastin on the inhibition of leucocyte elastase by alpha1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem J 1986; 238: 269–73
- Gauthier F, Fryksmark U, Ohlsson K, Bieth J. Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor. Biochim Biophys Acta 1982; 700: 178–83
- Smith C E, Johnson D A. Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinase. Biochem J 1985; 225: 436–72
- Hochstrasser K, Albrecht G J, Schönberger O L, Rasche B, Lempart K. An elastase-specific inhibitor from human bronchial mucus. Isolation and characterization. Hoppe Seylers Z Physiol Chem 1981; 362: 1369–75